Prodrug-activating systems in suicide gene therapy

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 105; no. 9; pp. 1161 - 1167
Main Authors Springer, C J, Niculescu-Duvaz, I
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.05.2000
Subjects
Antineoplastic Agents - metabolism
Antineoplastic Agents - therapeutic use
Genetic Therapy - methods
Neoplasms - enzymology
Neoplasms - genetics
Prodrugs - metabolism
Prodrugs - therapeutic use
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Address correspondence to: Caroline J. Springer, Cancer Research Campaign Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom. Phone: 44-208-722-4214; Fax: 44-208-643-6902; E-mail: caroline@icr.ac.uk.
ISSN:0021-9738
DOI:10.1172/JCI10001